# Careseng 1370 for Chemotherapy-Induced Myelosuppression

> **NCT03692780** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Careseng Biotech Co., Ltd.**

## Conditions studied

- Chemotherapy-Induced Myelosuppression

## Interventions

- **DRUG:** Careseng 1370
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03692780
- **Lead sponsor:** Careseng Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-03
- **Primary completion:** 2021-03
- **Final completion:** 2021-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** At sponsor's discretion
- **Last updated:** 2018-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03692780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03692780, "Careseng 1370 for Chemotherapy-Induced Myelosuppression". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03692780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*